INDEMNITY AGREEMENTIndemnification Agreement • January 15th, 2021 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionTHIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , is made by and between BOLT BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company” or “Bolt”), and (“Indemnitee”).
SUPPLY AGREEMENTSupply Agreement • January 15th, 2021 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionThis Supply Agreement (the “Agreement”) is made and entered into as of March 10, 2019 (the “Effective Date”) by and between EirGenix, Inc., a Taiwanese corporation having its principal place of business at No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei City 22180, Taiwan (“EirGenix”), and Bolt Biotherapeutics, Inc., a Delaware corporation having its principal place of business at 640 Galveston Drive, Redwood City, CA 94063 USA (“Bolt”).
SUBLEASE AGREEMENTSublease Agreement • January 15th, 2021 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionTHIS SUBLEASE AGREEMENT (the “Sublease”) is made and entered into as of the 18th day of April, 2019 by and between ARMO BIOSCIENCES, INC., a Delaware corporation (“Sublandlord”) and BOLT BIOTHERAPEUTICS, INC., a Delaware corporation (“Subtenant”), all with respect to the following:
CONSENT TO SUBLEASE AGREEMENTConsent to Sublease Agreement • January 15th, 2021 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionTHIS CONSENT TO SUBLEASE AGREEMENT (this “Agreement”) is made as of June 14, 2019, by and among HCP LS REDWOOD CITY, LLC, a Delaware limited liability company (“Landlord”), ARMO BIOSCIENCES, INC., a Delaware corporation (“Tenant”), and BOLT BIOTHERAPEUTICS, INC., a Delaware corporation (“Subtenant”).
EXCLUSIVE AGREEMENTExclusive Agreement • January 15th, 2021 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionThis Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education having powers under the laws of the State of California, and BOLT BIOTHERAPEUTICS, INC. (“Bolt”), a company having a primary place of business at 640 Galveston Drive, Redwood City, CA 94063, is effective on the 1st day of June, 2018 (“Effective Date”).